We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+16.76%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.6B
AUM Growth
+$2.65B
(+12%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
14.38%
Holding
1,445
New
151
Increased
481
Reduced
509
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$56.6M |
| 2 |
Fidelity National Information Services
FIS
|
+$53M |
| 3 |
Advanced Micro Devices
AMD
|
+$48.1M |
| 4 |
RTX Corp
RTX
|
+$43.3M |
| 5 |
Analog Devices
ADI
|
+$38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$72.1M |
| 2 |
PepsiCo
PEP
|
+$70.8M |
| 3 |
American Express
AXP
|
+$70.7M |
| 4 |
Automatic Data Processing
ADP
|
+$49.7M |
| 5 |
Synchrony
SYF
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.67% |
| 2 | Healthcare | 15.33% |
| 3 | Consumer Discretionary | 10% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
ManpowerGroup
MAN
$2.69B
| $3.1M | 0.01% |
37,501
-168,799
| -82% | -$13.3M |
|
|
CYBR
752
DELISTED
CyberArk
CYBR
| $3.09M | 0.01% |
25,974
| – | – |
|
753
Henry Schein
HSIC
$9.67B
| $3.08M | 0.01% |
51,248
-158,789
| -76% | -$9.58M |
|
|
MNR
754
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $3.06M | 0.01% |
+232,400
| New | +$3.08M |
|
755
Infosys
INFY
$44.9B
| $3M | 0.01% |
274,077
+6,400
| +2% | +$67.7K |
|
756
Allogene Therapeutics
ALLO
$584M
| $2.99M | 0.01% |
+103,285
| New | +$3M |
|
757
Bruker
BRKR
$9.24B
| $2.96M | 0.01% |
77,000
-156,400
| -67% | -$5.64M |
|
758
Dell
DELL
$358B
| $2.96M | 0.01% |
99,331
+79,727
| +407% | +$2.1M |
|
|
DCPH
759
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.92M | 0.01% |
125,864
| – | – |
|
760
PC Connection
CNXN
$2.2B
| $2.9M | 0.01% |
79,100
+41,964
| +113% | +$1.51M |
|
761
Corning
GLW
$124B
| $2.85M | 0.01% |
86,081
-92,760
| -52% | -$3.04M |
|
762
Vistra
VST
$47.1B
| $2.85M | 0.01% |
109,412
+97,930
| +853% | +$2.47M |
|
|
PDM
763
Piedmont Realty Trust
PDM
$1.17B
| $2.84M | 0.01% |
+136,159
| New | +$2.68M |
|
|
DBS
764
DELISTED
Invesco DB Silver Fund
DBS
| $2.81M | 0.01% |
125,880
| – | – |
|
765
Nucor
NUE
$59.1B
| $2.8M | 0.01% |
47,906
-25,098
| -34% | -$1.47M |
|
766
AXIS Capital
AXS
$7.27B
| $2.78M | 0.01% |
50,700
+8,000
| +19% | +$443K |
|
767
Lam Research
LRCX
$337B
| $2.76M | 0.01% |
154,430
-98,220
| -39% | -$1.64M |
|
768
Resources Connection
RGP
$139M
| $2.76M | 0.01% |
166,722
+6,300
| +4% | +$105K |
|
|
EXTN
769
DELISTED
Exterran Corporation
EXTN
| $2.73M | 0.01% |
161,846
+16,196
| +11% | +$288K |
|
770
Donnelley Financial Solutions
DFIN
$1.2B
| $2.73M | 0.01% |
183,200
+2,000
| +1% | +$30.1K |
|
771
Vera Bradley
VRA
$114M
| $2.7M | 0.01% |
203,799
+6,700
| +3% | +$68.5K |
|
772
iShares MSCI France ETF
EWQ
$344M
| $2.7M | 0.01% |
91,567
| – | – |
|
|
INXN
773
DELISTED
Interxion Holding N.V.
INXN
| $2.69M | 0.01% |
40,351
-7,205
| -15% | -$446K |
|
774
iShares MSCI Australia ETF
EWA
$1.26B
| $2.69M | 0.01% |
124,915
| – | – |
|
775
Stanley Black & Decker
SWK
$13.4B
| $2.69M | 0.01% |
19,718
-56,613
| -74% | -$7.38M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2019 Portfolio in Review
As of Q1 2019, Axa held 1,445 positions worth $25.6B, up 12% from $22.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa withdrew a net $1.17B in Q1 2019, closing 137 positions and reducing 509 holdings. Its most notable exit was Newfield Exploration, an estimated $15.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Axa opened a new position in BlackBerry worth $40.1M.
- Axa's largest Q1 2019 buy was BlackBerry: 3,971,844 shares worth $40.1M.
- Axa added most to Gilead Sciences in Q1 2019, an estimated $56.6M increase.
- Axa's biggest Q1 2019 reduction was Humana, cutting an estimated $72.1M.
- Axa fully exited Newfield Exploration in Q1 2019, selling an estimated $15.3M.
- Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q1 2019.
- Axa opened 151 new positions and closed 137 in Q1 2019.
- Axa's portfolio value rose 12% quarter-over-quarter to $25.6B.
Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.